Sacral nerve stimulation devices Sacral nerve stimulation (SNS) has been used to treat OAB for several decades. The SNS device is implanted above the buttocks. A lead sends electricalimpulses to the sacral nerves to calm the bladder.

The global Sacral Nerve Stimulation (SNS) Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Sacral Nerve Stimulation (SNS) Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sacral Nerve Stimulation (SNS) Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Medtronic
Boston Scientific
Abbott
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Implantable VNS Devices
External VNS Devices

Segment by Application
Hospitals
Clinics
Other